Results 21 to 30 of about 46,488 (301)

Lipoprotein Characteristics and Incident Coronary Heart Disease: Prospective Cohort of Nearly 90 000 Individuals in UK Biobank

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Associations of coronary heart disease (CHD) with plasma lipids are well described, but the associations with characteristics of lipoproteins (which transport lipids) remain unclear. Methods and Results UK Biobank is a prospective study of 0.5 
Danyao Jin   +5 more
doaj   +1 more source

Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects. [PDF]

open access: yesArteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
Analysis of human plasma by gradient gel electrophoresis (GGE) revealed multiple distinct bands in the size range between very low density (VLDL) and low density lipoproteins (LDL). GGE of intermediate density lipoproteins (IDL) from normal subjects consistently showed two major bands with particle diameters in the range of 275 to 300 A.
R M Krauss, C Giotas, T A Musliner
openaire   +2 more sources

Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease

open access: yeseLife, 2021
Adherence to healthy lifestyles is associated with reduced risk of coronary heart disease (CHD), but uncertainty persists about the underlying lipid pathway.
Jiahui Si   +16 more
doaj   +1 more source

Risk Factors for Polyvascular Involvement in Patients With Peripheral Artery Disease: A Mendelian Randomization Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Atherosclerosis in >1 vascular bed (ie, polyvascular disease), often a feature of peripheral artery disease (PAD), is associated with high morbidity and mortality.
Ozan Dikilitas   +2 more
doaj   +1 more source

Neonatal umbilical cord blood lipoproteins. Isolation and characterization of intermediate density and low density lipoproteins. [PDF]

open access: yesArteriosclerosis: An Official Journal of the American Heart Association, Inc., 1982
Intermediate density lipoproteins (IDL) (d = 1.006 to 1.019 g/ml) and low density lipoproteins (LDL) (d = 1.019 to 1.063 g/ml) were isolated from human umbilical cord blood plasma by sequential ultracentrifugation. The concentration, chemical and apolipoprotein composition, size and size distribution of the neonatal IDL and LDL for both sexes were ...
P A Davis, T M Forte
openaire   +3 more sources

10-YEAR RISK ESTIMATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS

open access: yesСхідноукраїнський медичний журнал, 2021
Introduction. Arterial hypertension is one of the most common causes of atherosclerotic cardiovascular disease, which is still the reason of mortality for a lot of persons.
Olha M. Chernatska, Xaba Sibongumusa
doaj   +1 more source

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundRemnant lipoproteins (RLPs), the triglyceride‐enriched precursors to low‐density lipoprotein, are an emerging risk factor for coronary heart disease (CHD).
Parag H. Joshi   +11 more
doaj   +1 more source

The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. [PDF]

open access: yesCirculation, 1987
Studies were undertaken to determine whether there is an association between elevated levels of intermediate-density lipoproteins (IDL) (Sf 12-60 lipoproteins) and coronary artery disease. Forty-five to sixty-five-year-old men with objectively documented coronary artery disease (n = 58) who were free of known risk factors (diabetes, hypertension ...
L Schwartz   +3 more
openaire   +3 more sources

Metabolic and Lipidomic Markers Differentiate COVID-19 From Non-Hospitalized and Other Intensive Care Patients

open access: yesFrontiers in Molecular Biosciences, 2021
Coronavirus disease 2019 (COVID-19) is a viral infection affecting multiple organ systems of great significance for metabolic processes. Thus, there is increasing interest in metabolic and lipoprotein signatures of the disease, and early analyses have ...
Franziska Schmelter   +27 more
doaj   +1 more source

Home - About - Disclaimer - Privacy